Encelimab, an anti-LAG3 antibody, inhibits the LAG-3/MHC II interaction to promote T-cell activation and, when used alone or alongside an anti-PD-1 antibody, shrinks tumors in a lymphoma mouse model (A20 cell xenograft) [1].
CAS Number:
[2173096-82-5]
* VAT and and shipping costs not included. Errors and price changes excepted
